Checkpoint Therapeutics, Inc. (CKPT)

Checkpoint Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	33.04	6.6	4.93	12.07	54.74	40.77
Cash & Short-Term Investments	33.04	6.6	4.93	12.07	54.74	40.77
Cash Growth	193.94%	34.01%	-59.16%	-77.95%	34.25%	56.35%
Receivables	-	-	-	0.07	0.02	0.02
Prepaid Expenses	1.12	0.87	0.45	1.15	0.98	1.8
Total Current Assets	34.16	7.47	5.38	13.29	55.73	42.6
Total Assets	34.16	7.47	5.38	13.29	55.73	42.6
Accounts Payable	14.74	6.09	6.57	11.54	16.14	3.44
Accrued Expenses	2.87	12.35	11.14	9.79	9.61	3.39
Other Current Liabilities	0.26	1.66	0.71	11.45	0.23	0.39
Total Current Liabilities	17.87	20.1	18.43	32.77	25.98	7.22
Total Liabilities	17.87	20.1	18.43	32.77	25.98	7.22
Common Stock	0.01	0.01	0	0	0	0.01
Additional Paid-In Capital	398.07	350.31	297.86	241.12	223.01	173.95
Retained Earnings	-381.79	-370.57	-314.33	-262.49	-199.86	-143.19
Comprehensive Income & Other	-	7.64	3.42	1.89	6.6	4.62
Shareholders' Equity	16.3	-12.63	-13.05	-19.48	29.75	35.38
Total Liabilities & Equity	34.16	7.47	5.38	13.29	55.73	42.6
Net Cash (Debt)	33.04	6.6	4.93	12.07	54.74	40.77
Net Cash Growth	193.94%	34.01%	-59.16%	-77.95%	34.25%	56.35%
Net Cash Per Share	0.71	0.17	0.18	1.17	6.47	7.30
Filing Date Shares Outstanding	83.06	83.76	35.69	12.95	9.06	7.52
Total Common Shares Outstanding	83.06	54.34	27.74	10.29	8.46	6.94
Working Capital	16.3	-12.63	-13.05	-19.48	29.75	35.38
Book Value Per Share	0.20	-0.23	-0.47	-1.89	3.52	5.10
Tangible Book Value	16.3	-12.63	-13.05	-19.48	29.75	35.38
Tangible Book Value Per Share	0.20	-0.23	-0.47	-1.89	3.52	5.10

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q